Lewis Earl Insider Trading Activity

Also formerly known as LEWIS EARL R
Average Profitability
28.78%
Insider Buys Quantity
9
Insider Buys Sum
$610,225.94
Insider Sells Quantity
1
Insider Sells Sum
$55,872.96

Insider Activity of Lewis Earl

According to the SEC Form 4 filings, Lewis Earl, being in a position of

  1. director at Tecogen Inc.,
    оver the last 12 months, has bought 10000 shares for $27,005, and sold 0 shares,
    over all time since 2026-03-26, has bought 10000 shares for $27,005, and sold 0 shares.

Biography of Lewis Earl

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $27,0052100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-03-27PurchaseTecogen Inc.
TGEN
director
5,000
0.0164%
$2.52$12,596+40.47%
2026-03-26PurchaseTecogen Inc.
TGEN
director
5,000
0.0184%
$2.88$14,409+37.02%
2017-05-25PurchaseHarvard Bioscience, Inc.
HBIO
director
12,238
0.036%
$2.35$28,765+50%
2017-05-24PurchaseHarvard Bioscience, Inc.
HBIO
director
5,000
0.0145%
$2.37$11,850+46.81%
2017-05-23PurchaseHarvard Bioscience, Inc.
HBIO
director
5,000
0.0144%
$2.39$11,950+42.71%
2016-12-06SaleHarvard Bioscience, Inc.
HBIO
director
23,088
0.0653%
$2.42$55,873+12.6%
2015-12-02PurchaseHarvard Bioscience, Inc.
HBIO
director
27,221
0.0813%
$3.28$89,285-13.46%
2009-09-16PurchaseHarvard Bioscience, Inc.
HBIO
director
11,068
0.0505%
$3.75$41,505-1.49%
2009-09-15PurchaseHarvard Bioscience, Inc.
HBIO
director
28,932
0.1308%
$3.72$107,529-1.49%
2008-12-02PurchaseHarvard Bioscience, Inc.
HBIO
director
30,000
0.126%
$2.06$61,651+58.59%
2008-12-01PurchaseHarvard Bioscience, Inc.
HBIO
director
20,000
0.088%
$2.03$40,644+67.74%
2007-12-11PurchaseHarvard Bioscience, Inc.
HBIO
director
50,000
0.2235%
$4.34$217,048+9.56%
Total: 12
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.